Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
13.14
-0.34 (-2.52%)
Aug 17, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015
Net Income
-110.09-3.48-23.27-10.4-21.4-16.98-0.03
Depreciation & Amortization
0.280.180.080.050.050.070
Share-Based Compensation
2.110.141.093.430.650.490
Other Operating Activities
85.29-9.54-1.741.111.820.710.01
Operating Cash Flow
-22.42-12.7-23.85-5.81-18.88-15.72-0.02
Capital Expenditures
-0.050-0.24-0.04-0.01-0.110
Acquisitions
25.2000000
Change in Investments
00000.0500
Investing Cash Flow
25.150-0.24-0.040.04-0.110
Dividends Paid
-4.41000000
Share Issuance / Repurchase
155.830048.237.20.020
Debt Issued / Paid
01.19000.312.280.04
Other Financing Activities
-9.62000000
Financing Cash Flow
141.81.19048.237.512.30.04
Net Cash Flow
144.53-11.51-24.0942.3518.65-3.530.01
Free Cash Flow
-22.47-12.7-24.09-5.85-18.89-15.83-0.02
Free Cash Flow Margin
-2006.20%-87.10%--29.00%---
Free Cash Flow Per Share
-2.52-5.00-8.90-2.58-13.07-278.50-0.07
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).